Clinical Trial Update: Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated glutamine as prophylaxis for irinotecan-induced diarrhea in metastatic colorectal cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Glutamine (glutamine)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED